Navigation Links
Jay Keasling wins Heinz Award
Date:9/12/2012

Jay Keasling, a leading authority and pioneer on synthetic biology who has engineered microbial "factories" to manufacture an affordable version of a frontline antimalarial drug and biofuel substitutes for gasoline, diesel and jet fuel, has won a 2012 Heinz Award, which is presented by the Heinz Family Foundation and carries with it a cash prize of $250,000.

Among his multiple titles, Keasling is the Associate Laboratory Director for Biosciences at the U.S. Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab), CEO for DOE's Joint BioEnergy Institute (JBEI), the Hubbard Howe Jr. Distinguished Professor of Biochemical Engineering at the University of California (UC) Berkeley, and director of the Synthetic Biology Engineering Research Center (SynBERC).

"Dr. Keasling is a pioneer in a field few people even know exists but that has profound implications for the future of medicine, chemistry and energy, and for the future of our planet," said Teresa Heinz, who chairs the Heinz Family Foundation, in announcing the award. "Dr. Keasling's research is revealing how we can use natural systems to produce cheaper, more environmentally-friendly compounds for everything from anti-malarial drugs to biofuels. His work, and the deep human compassion that drives it, is proof that we really can invent our way to a more sustainable future."

This year marks the 18th annual presentation of the Heinz Awards which are intended to honor outstanding individuals who have made significant contributions in five areas: Arts and Humanities; Environment; Human Condition; Public Policy; and Technology, the Economy and Employment. The awards were established by Teresa Heinz in 1993 to honor the memory of her late husband, U.S. Senator John Heinz. In addition to the monetary award, recipients are presented with a medallion. The 2012 Heinz Awards will be presented at a ceremony in Pittsburgh, Pennsylvania on October 11.

Keasling, 48,
'/>"/>

Contact: Lynn Yarris
lcyarris@lbl.gov
510-486-5375
DOE/Lawrence Berkeley National Laboratory
Source:Eurekalert  

Page: 1 2 3 4

Related biology news :

1. Keck award enables Carnegie Mellon and Stanford to dramatically expand crowdsourced RNA design
2. MARC travel awards announced for EB 2012
3. Space research institute honors Sen. Hutchison with Pioneer Award
4. Autism Speaks awards $1.1 million to fund high priority studies
5. Young Scientist Award for Socio- and Econophysics 2012 for Arne Traulsen
6. MARC travel award announced for the 2012 ASCI/AAP Joint Meeting
7. Renowned geneticist R. Rodney Howell receives ACMG Foundation Lifetime Achievement Award
8. Genzyme/ACMG Foundation Genetics Training Award in Clinical Biochemical Genetics announced
9. 2012 ACMG Foundation/Signature Genomic Laboratories Travel Award winner announced
10. NYU School of Medicine presents 2012 Dart/NYU Biotechnology Achievement Awards
11. Copernicus Award 2012 for German-Polish collaboration in business information systems
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Jay Keasling wins Heinz Award
(Date:4/13/2015)... 13, 2015  higi, a leading cloud-based consumer engagement ... fully engage with their communities around health and wellness, ... and secure API.  ... accessible, affordable, and convenient vehicle to receive validated health ... The API will allow higi,s trusted partners, ...
(Date:4/9/2015)... Calif. , April 9, 2015 Synaptics ... interface solutions, announced today that it will report financial ... Thursday, April 23, 2015, after the close of market. ... analysts and investors at 2:00 p.m. PT (5:00 p.m. ... To participate on the live call, analysts ...
(Date:4/6/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... on the growing mobile commerce market, announced today ... MINIATURE, MULTI-PURPOSE ANTENNA METHOD AND SYSTEM FOR ... introduces a new revolutionary method and system to ... of miniature antenna modules for multiple purposes including ...
Breaking Biology News(10 mins):higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 2higi Launches Seamless Access to HIPAA-Compliant Health Outcomes and Activity Data 3Synaptics to Report Third Quarter Results on April 23 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4
... Extra genomes appear, on average, to offer no benefit or ... the origin of new species, say scientists from Indiana University ... of the National Academy of Sciences . Plant biologists ... chromosome sets -- was a gateway to speciation. But the ...
... Folsom, CA August 11, 2009 On Monday, August ... 90th Annual Pacific Division Meeting of the AAAS in San ... science communication from some of the brightest minds in the ... Part of the Job: Communicating Science to the Public. (Online ...
... at Oregon State University have discovered that the circadian rhythms ... more susceptible to pesticides at some times of the day ... it may be possible to tap into this genetic characteristic, ... to a specific pesticide, and use that information to increase ...
Cached Biology News:Genome duplication responsible for more plant species than previously thought 2Genome duplication responsible for more plant species than previously thought 3Science communication to take the stage at annual AAAS meeting in San Francisco 2Biological clocks of insects could lead to more effective pest control 2Biological clocks of insects could lead to more effective pest control 3
(Date:4/21/2015)... Contract Research Organization XenoTech, LLC , a ... new 41,500 ft2 facility. The planned move will double ... W. 116th St. in Lenexa, KS. The new facility, ... space, will remain in the Kansas City metro area, just ... twenty years ago. Remaining in the Kansas City area ...
(Date:4/21/2015)... April 21, 2015 Merrimack Pharmaceuticals, Inc. (Nasdaq: ... multi-arm Phase 1 study of MM-141, a bispecific antibody ... an oral session by Dr. Mansoor Saleh , ... Annual Meeting in Philadelphia, PA. ... as a monotherapy and in combination with everolimus or ...
(Date:4/21/2015)... 21, 2015  Cryoport, Inc. (OTCBB: CYRX) ... logistics solutions for the life sciences industry, ... lines, clinical research organizations, vaccine manufacturers and ... Mark W. Sawicki , Chief Commercial Officer, ... Summit in San Francisco, CA ...
(Date:4/21/2015)... April 21, 2015 PRC Clinical, ... and exhibit at the ACRP 2015 Global Conference and ... Utah. The Association of Clinical Research Professionals (ACRP) Global ... conference solely focused on the conduct of clinical trials. ... development, and widely recognized industry certifications. , The ...
Breaking Biology Technology:XenoTech Plans Expansion to New Global Headquarters after Impressive Revenue Growth in 2014 2XenoTech Plans Expansion to New Global Headquarters after Impressive Revenue Growth in 2014 3First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 2First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 3First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 4First-in-Human Phase 1 Trial of MM-141 Demonstrates Activity in Biomarker Positive Patients 5Cryoport to Present at the 3rd Annual BioLogistics Summit in San Francisco, CA 2Cryoport to Present at the 3rd Annual BioLogistics Summit in San Francisco, CA 3PRC Clinical Sponsors The ACRP 2015 Global Conference And Meets Biotech Companies in the Salt Lake City Area. 2
... Pharma, Inc., a privately-,held, specialty pharmaceutical company, announced ... A financing, which included investors Domain Associates,Latterell Venture ... is committed to the development of prescription,products based ... the unmet,needs of patients and their caregivers. Meritage ...
... Gen-Probe Incorporated,(Nasdaq: GPRO ) announced today that the ... Annual Growth Stock on Wednesday, June 18, 2008 at,approximately ... be,webcast live and may be accessed through a link ... http://www.gen-probe.com . The webcast will be,available for 30 days ...
... - Potential to combine compounds with multiple new and existing ... with activity ... against drug-resistant organisms -, SAN DIEGO and LONDON, June ... have entered into a,worldwide strategic alliance for the discovery, development ...
Cached Biology Technology:Meritage Pharma, Inc. Announces Company Formation and $22.5M Series A Financing 2Gen-Probe to Webcast Presentation at the William Blair & Company 28th Annual Growth Stock Conference 2GlaxoSmithKline and Mpex Pharmaceuticals Form Alliance to Develop Novel Efflux Pump Inhibitors for Use Against Serious Gram-Negative Infections 2GlaxoSmithKline and Mpex Pharmaceuticals Form Alliance to Develop Novel Efflux Pump Inhibitors for Use Against Serious Gram-Negative Infections 3GlaxoSmithKline and Mpex Pharmaceuticals Form Alliance to Develop Novel Efflux Pump Inhibitors for Use Against Serious Gram-Negative Infections 4GlaxoSmithKline and Mpex Pharmaceuticals Form Alliance to Develop Novel Efflux Pump Inhibitors for Use Against Serious Gram-Negative Infections 5
Luminometers...
...
Cell Lysis Buffer is used to lyse cells under nondenaturing conditions....
LECHNER AND LaVECK MEDIUMfor the clonal growth of normal human bronchial and other epithelial cells. Requires additives. With glutamine.Recommended storage condition:oC to 8oCIntended use(s):research...
Biology Products: